Related Experiment Video
Updated: Aug 15, 2025

07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
11.7K
Environmental changes surrounding congenital heart disease.
1Department of Pediatrics, Bucheon Sejong Hospital, Bucheon, Korea.
Clinical and Experimental Pediatrics
|January 3, 2023
Summary
Adult congenital heart disease (CHD) patients are increasing, facing more adult diseases and complex cardiac issues. This review examines the clinical usefulness of new data and treatments for managing these growing challenges.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease
- Medical Technology
Background:
- Improving outcomes for congenital heart disease (CHD) leads to a growing adult CHD population.
- Adult CHD patients increasingly present with common adult diseases (e.g., diabetes, hypertension) and complex cardiac conditions (e.g., heart failure, arrhythmias).
- The medical burden associated with adult CHD is rising due to these comorbidities and residual cardiac issues.
Purpose of the Study:
- To systematically review the clinical usefulness of the vast amount of data collected.
- To explore advancements in risk stratification, surgical techniques, transcatheter interventions, and electronic monitoring devices.
- To highlight the expanding therapeutic options for adult CHD patients.
Main Methods:
- Systematic review of clinical data and technological advancements.
- Analysis of information from miniaturized and diversified electronic monitoring instruments.
- Evaluation of evolving surgical techniques, prostheses, and transcatheter intervention instruments.
Main Results:
- Growing genetic knowledge supports active medical support and risk stratification.
- Surgical and transcatheter intervention options are diversifying and expanding.
- Electronic monitoring devices provide a vast amount of data for clinical assessment.
Conclusions:
- A multidisciplinary team approach is essential for managing adult CHD patients with advanced heart failure.
- Continuous evaluation of clinical data and technological advancements is crucial for optimizing patient care.
- The expanding therapeutic landscape offers new possibilities for improving outcomes in adult CHD.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
30
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Heart Failure I: Introduction
40
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
40
Imbalances in Cardiac Output
1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Mitral Stenosis I: Introduction
25
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Cardiomyopathy V: Interprofessional Care
25
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K

